Altimmune (ALT) Insider Trading & Ownership $5.07 +0.10 (+1.91%) As of 02:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Altimmune (NASDAQ:ALT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$52,000.00Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$110,475.90 Get ALT Insider Trade Alerts Want to know when executives and insiders are buying or selling Altimmune stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ALT Insider Buying and Selling by Quarter Altimmune Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/13/2025Gregory L WeaverCFOBuy10,000$5.20$52,000.00 8/19/2024David DrutzDirectorSell16,011$6.90$110,475.90 (Data available from 1/1/2013 forward) ALT Insider Trading Activity - Frequently Asked Questions Who is on Altimmune's Insider Roster? The list of insiders at Altimmune includes David Drutz, Diane Jorkasky, Gregory L Weaver, M Scot Roberts, Matthew Scott Harris, Vipin K Garg, and Wayne Pisano. Learn more on insiders at ALT. What percentage of Altimmune stock is owned by insiders? 4.10% of Altimmune stock is owned by insiders. Learn more on ALT's insider holdings. Which Altimmune insiders have been buying company stock? The following insiders have purchased ALT shares in the last 24 months: David Drutz ($864.00), and Gregory L Weaver ($52,000.00). How much insider buying is happening at Altimmune? Insiders have purchased a total of 10,300 ALT shares in the last 24 months for a total of $52,864.00 bought. Which Altimmune insiders have been selling company stock? The following insider sold ALT shares in the last 24 months: David Drutz ($110,475.90). How much insider selling is happening at Altimmune? Insiders have sold a total of 16,011 Altimmune shares in the last 24 months for a total of $110,475.90 sold. Altimmune Key ExecutivesDr. Vipin K. Garg Ph.D. (Age 66)President, CEO & Director Compensation: $986.14kDr. Matthew Scott Harris AGAF (Age 71)FCAP, M.D., MS, Chief Medical Officer Compensation: $681.81kMr. Raymond M. Jordt M.B.A. (Age 51)Chief Business Officer Compensation: $578.85kMr. Richard I. Eisenstadt M.B.A. (Age 66)Chief Financial Officer Compensation: $619.69kMr. Bertrand Georges Ph.D.Chief Technology OfficerDr. M. Scot Roberts Ph.D. (Age 65)Chief Scientific Officer Compensation: $599.25kMr. Tony Blandin B.S.Vice President of Quality & Compliance ManagementMr. Andrew Shutterly M.S.Corporate Controller More Insider Trading Tools from MarketBeat Related Companies ARS Pharmaceuticals Insider Selling Disc Medicine Insider Selling Vera Therapeutics Insider Selling Immunocore Insider Selling Travere Therapeutics Insider Selling Edgewise Therapeutics Insider Selling Ocular Therapeutix Insider Selling Amphastar Pharmaceuticals Insider Selling Adaptive Biotechnologies Insider Selling Iovance Biotherapeutics Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market Sentiment This page (NASDAQ:ALT) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Intuitive Surgical at $1.99. Nvidia at $11. Shorting Fannie Mae months before collapse. That’s this analyst’s ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Altimmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Altimmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALT Stock Free ALT Stock Alerts